vs

Side-by-side financial comparison of Orchestra BioMed Holdings, Inc. (OBIO) and Rumble Inc. (RUM). Click either name above to swap in a different company.

Orchestra BioMed Holdings, Inc. is the larger business by last-quarter revenue ($30.9M vs $27.1M, roughly 1.1× Rumble Inc.). Orchestra BioMed Holdings, Inc. runs the higher net margin — 20.2% vs -120.8%, a 141.0% gap on every dollar of revenue. On growth, Orchestra BioMed Holdings, Inc. posted the faster year-over-year revenue change (12120.2% vs -10.5%). Orchestra BioMed Holdings, Inc. produced more free cash flow last quarter ($-2.3M vs $-31.7M).

Orchestra BioMed Holdings, Inc. is a clinical-stage medical technology company focused on developing novel, evidence-based therapeutic solutions for cardiovascular and other high-burden chronic diseases. It collaborates with leading healthcare stakeholders, operates primarily across North American and European markets, with core segments covering interventional cardiology and chronic disease care optimization.

Rumble is a Canadian-American online video platform, web hosting, and cloud services business headquartered in Toronto, Canada, with its U.S. headquarters in Longboat Key, Florida. It was founded in 2013 by Chris Pavlovski, a Canadian technology entrepreneur. Rumble's cloud services business hosts Truth Social, and the video platform is popular among American conservative and far-right users. Rumble has been described as "alt-tech".

OBIO vs RUM — Head-to-Head

Bigger by revenue
OBIO
OBIO
1.1× larger
OBIO
$30.9M
$27.1M
RUM
Growing faster (revenue YoY)
OBIO
OBIO
+12130.6% gap
OBIO
12120.2%
-10.5%
RUM
Higher net margin
OBIO
OBIO
141.0% more per $
OBIO
20.2%
-120.8%
RUM
More free cash flow
OBIO
OBIO
$29.4M more FCF
OBIO
$-2.3M
$-31.7M
RUM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OBIO
OBIO
RUM
RUM
Revenue
$30.9M
$27.1M
Net Profit
$6.2M
$-32.7M
Gross Margin
99.8%
5.5%
Operating Margin
21.8%
-131.1%
Net Margin
20.2%
-120.8%
Revenue YoY
12120.2%
-10.5%
Net Profit YoY
138.7%
86.2%
EPS (diluted)
$0.28
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OBIO
OBIO
RUM
RUM
Q4 25
$30.9M
$27.1M
Q3 25
$24.8M
Q1 25
$23.7M
Q4 24
$30.2M
Q3 24
$25.1M
Q2 24
$22.5M
Q1 24
$17.7M
Q4 23
$20.4M
Net Profit
OBIO
OBIO
RUM
RUM
Q4 25
$6.2M
$-32.7M
Q3 25
$-16.3M
Q1 25
$-2.7M
Q4 24
$-236.8M
Q3 24
$-31.5M
Q2 24
$-26.8M
Q1 24
$-43.3M
Q4 23
$-29.3M
Gross Margin
OBIO
OBIO
RUM
RUM
Q4 25
99.8%
5.5%
Q3 25
-1.8%
Q1 25
-26.7%
Q4 24
-14.2%
Q3 24
-45.4%
Q2 24
-58.8%
Q1 24
-79.5%
Q4 23
Operating Margin
OBIO
OBIO
RUM
RUM
Q4 25
21.8%
-131.1%
Q3 25
-113.6%
Q1 25
-153.5%
Q4 24
-80.1%
Q3 24
-131.0%
Q2 24
-172.7%
Q1 24
-197.4%
Q4 23
-182.5%
Net Margin
OBIO
OBIO
RUM
RUM
Q4 25
20.2%
-120.8%
Q3 25
-65.7%
Q1 25
-11.2%
Q4 24
-783.2%
Q3 24
-125.9%
Q2 24
-119.2%
Q1 24
-244.1%
Q4 23
-143.6%
EPS (diluted)
OBIO
OBIO
RUM
RUM
Q4 25
$0.28
$-0.13
Q3 25
$-0.06
Q1 25
$-0.01
Q4 24
$-1.17
Q3 24
$-0.15
Q2 24
$-0.13
Q1 24
$-0.21
Q4 23
$-0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OBIO
OBIO
RUM
RUM
Cash + ST InvestmentsLiquidity on hand
$106.5M
$237.9M
Total DebtLower is stronger
$15.0M
Stockholders' EquityBook value
$53.6M
$274.8M
Total Assets
$114.9M
$336.8M
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OBIO
OBIO
RUM
RUM
Q4 25
$106.5M
$237.9M
Q3 25
$269.8M
Q1 25
$301.3M
Q4 24
$114.0M
Q3 24
$132.0M
Q2 24
$154.2M
Q1 24
$183.8M
Q4 23
$219.5M
Total Debt
OBIO
OBIO
RUM
RUM
Q4 25
$15.0M
Q3 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Stockholders' Equity
OBIO
OBIO
RUM
RUM
Q4 25
$53.6M
$274.8M
Q3 25
$302.2M
Q1 25
$339.6M
Q4 24
$-63.1M
Q3 24
$166.1M
Q2 24
$192.7M
Q1 24
$210.7M
Q4 23
$251.6M
Total Assets
OBIO
OBIO
RUM
RUM
Q4 25
$114.9M
$336.8M
Q3 25
$367.2M
Q1 25
$391.1M
Q4 24
$195.3M
Q3 24
$217.2M
Q2 24
$243.2M
Q1 24
$263.0M
Q4 23
$295.7M
Debt / Equity
OBIO
OBIO
RUM
RUM
Q4 25
0.28×
Q3 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OBIO
OBIO
RUM
RUM
Operating Cash FlowLast quarter
$-2.3M
$-29.4M
Free Cash FlowOCF − Capex
$-2.3M
$-31.7M
FCF MarginFCF / Revenue
-7.4%
-117.2%
Capex IntensityCapex / Revenue
0.1%
8.5%
Cash ConversionOCF / Net Profit
-0.36×
TTM Free Cash FlowTrailing 4 quarters
$-70.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OBIO
OBIO
RUM
RUM
Q4 25
$-2.3M
$-29.4M
Q3 25
$-10.6M
Q1 25
$-14.5M
Q4 24
$-12.4M
Q3 24
$-19.1M
Q2 24
$-21.7M
Q1 24
$-33.9M
Q4 23
$-33.1M
Free Cash Flow
OBIO
OBIO
RUM
RUM
Q4 25
$-2.3M
$-31.7M
Q3 25
$-12.0M
Q1 25
$-14.6M
Q4 24
$-12.4M
Q3 24
$-19.9M
Q2 24
$-23.1M
Q1 24
$-34.3M
Q4 23
$-36.6M
FCF Margin
OBIO
OBIO
RUM
RUM
Q4 25
-7.4%
-117.2%
Q3 25
-48.6%
Q1 25
-61.7%
Q4 24
-40.9%
Q3 24
-79.5%
Q2 24
-102.8%
Q1 24
-193.3%
Q4 23
-179.7%
Capex Intensity
OBIO
OBIO
RUM
RUM
Q4 25
0.1%
8.5%
Q3 25
5.7%
Q1 25
0.6%
Q4 24
0.1%
Q3 24
3.4%
Q2 24
6.1%
Q1 24
2.4%
Q4 23
17.5%
Cash Conversion
OBIO
OBIO
RUM
RUM
Q4 25
-0.36×
Q3 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OBIO
OBIO

Segment breakdown not available.

RUM
RUM

Audience Monetization$23.8M88%
Other Initiatives$3.3M12%

Related Comparisons